PUBLIC CONTRACT · 2024

Aquisição de IMUNOGLOBULINA HUMANA NORMAL C/HIALURONIDASE 100 MG/ML SOL INJ FR 200 ML SC + IMUNOGLOBULINA HUMANA NORMAL C/HIALURONIDASE 100 MG/ML SOL INJ FR 100 ML SC ao abrigo do CPA 2023/438

Contract value
€10,530.00
Signed on
24 September 2024
Procedure
Ao abrigo de acordo-quadro (art.º 259.º)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 10937964

PUBLISHED SUBJECT

Aquisição de IMUNOGLOBULINA HUMANA NORMAL C/HIALURONIDASE 100 MG/ML SOL INJ FR 200 ML SC + IMUNOGLOBULINA HUMANA NORMAL C/HIALURONIDASE 100 MG/ML SOL INJ FR 100 ML SC ao abrigo do CPA 2023/438

Parties involved

Place of performance
Portugal, Porto, Porto
NUTS region
PT11A - Área Metropolitana do Porto

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee
TAKEDA FARMACÊUTICOS PORTUGAL, Lda. · Tax ID 502801204

Values and timeline

Contract price
€10,530.00
Procedure base price
€10,530.00
Total effective price
Not reported on Portal BASE
Publication date
26 September 2024
Award date
24 September 2024
Signing date
24 September 2024
Performance period
122 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type
Aquisição de bens móveis
Procedure type
Ao abrigo de acordo-quadro (art.º 259.º)
Award criterion
Monofator
CPV code
33600000-6 - Produtos farmacêuticos
Legal basis
Artigo 259.º do Código dos Contratos Públicos
Regime
Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
Framework agreement
438/2023 - Acordo-quadro para fornecimento de derivados do plasma humano
Centralised procedure
No
Environmental criterion
No
Notice
Not stated
Procedure identifier
7208712

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts